The macular carotenoids lutein (L) and zeaxanthin (Z) are obtained via diet and accumulate in the central retina where they are referred to as macular pigment. The density of this biomarker (macular pigment optical density; MPOD) has been positively correlated with cognitive functioning via measures of global cognition, processing speed, and visual-spatial abilities, among others. Although improvements in cognitive function have been found in adults, much less is known about how L and Z intake may support or improve cognitive functioning during periods of rapid developmental change, such as childhood and pre-adolescence. This study examined the relationship between MPOD and cognitive functioning in 51 7–13-year-old children (51% female). MPOD was measured using heterochromatic flicker photometry (HFP) optimized for this age group. Cognitive function was assessed using the Woodcock-Johnson III (composite standard scores were obtained for Brief Intellectual Ability, Verbal Ability, Cognitive Efficiency, Processing Speed, and Executive Processes). In this sample, MPOD was significantly related to Executive Processes, r(47) = 0.288, p < 0.05, and Brief Intellectual Ability, r(47) = 0.268, p < 0.05. The relationship to Cognitive Efficiency was positive and trending but not significant, r(49) = 0.206, p = 0.074. In general, these data are consistent with those of adults showing a link between higher carotenoid status and improved cognitive functioning.
Processing speed, which can be measured behaviorally in various sensory domains, has been shown to be a strong marker of central nervous system health and functioning in adults. Visual temporal processing speed (measured via critical flicker fusion [CFF] thresholds) represents the maximum speed at which the visual system can detect changes. Previous studies of infant CFF development have been limited and inconsistent. The present study sought to characterize the development of CFF thresholds in the first year of life using a larger sample than previous studies and a repeated measures design (in Experiment 2) to control for individual differences. Experiment 1 (n=44 infants and n=24 adults) used a cross-sectional design aimed at examining age-related changes that exist in CFF thresholds across infants during the first year of life. Adult data were collected to give context to infant CFF thresholds obtained under our specific stimulus conditions. Experiment 2 (N=28) used a repeated-measures design to characterize the developmental trajectory of infant CFF thresholds between three and six months of age, based on the results of Experiment 1. Our results reveal a general increase in CFF from three to four and one-half months of age, with a high degree of variability within each age group. Infant CFF thresholds at 4.5months of age were not significantly different from the adult average, though a regression analysis of the data from Experiment 2 predicted that infants would reach the adult average closer to 6months of age. Developmental and clinical implications of these data are discussed.
As the older population increases, the number of persons living with dementia (PWD) will increase as well. Yet, at the same time, there are fewer health care professionals per care recipient. To address the rising demand on healthcare professionals and informal care partners of PWD, socially assistive robots (SARs) can potentially facilitate care provision. It is crucial to understand the divergent tasks of these two caregiver groups so that the SAR’s intervention can meet each group’s needs. This qualitative study investigated and compared both caregiver groups’ acceptance of a SAR. Six use cases involving a SAR (NAO, SoftBank) were demonstrated to both caregiver groups (N=20 persons). Both groups expressed willingness to adopt such technology and found that it could be useful in dementia care. However, participants’ perceptions varied by task. Results indicate that healthcare professionals focused more on the assistive aspects, whereas care partners focused more on the social aspects of the SAR.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.